iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity

BACKGROUND: Tamoxifen (Tam) is the most frequent treatment for estrogen receptor (ER) positive breast cancer. We recently showed that fibronectin (FN) leads to Tam resistance and selection of breast cancer stem cells. With the aim of developing a nanoformulation that would simultaneously tackle ER a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nanobiotechnology
Main Authors: Diaz Bessone, María Inés, Simón-Gracia, Lorena, Scodeller, Pablo, Ramirez, María de los Angeles, Lago Huvelle, María Amparo, Soler-Illia, Galo J. A. A., Simian, Marina
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6898937/
https://ncbi.nlm.nih.gov/pubmed/31812165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-019-0553-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados